Sage Therapeutics Evaluates Resource Allocation and Potential Cuts Following FDA Setback
Sage Therapeutics, in collaboration with partner Biogen, has experienced a setback in their efforts to secure U.S. Food and Drug Administration (FDA) approval for their depression drug...